Shock, Septic: all 890 studies

Page 8 of 9. Open to participants first (210), then studies with results posted, then the rest; newest registration first within each.

• GM-CSF to Decrease ICU Acquired InfectionsCompletedNCT02361528Phase 3
• Mortality Reduction in Septic Shock by Plasma AdsorptionTerminatedNCT02357433Not applicable
• Echo vs. EGDT in Severe Sepsis and Septic ShockCompletedNCT02354742Not applicable
• VTE Incidence in Severe Sepsis and Septic ShockCompletedNCT02353910
• Long-term Cognitive and Cerebral Changes in Sepsis Survivors and Their PredictorsStatus unknownNCT02339649Not applicable
• Balanced Salt Solution VS. Normal Saline Solution in Septic ShockCompletedNCT02336620Phase 3
• ASSET - a Double-Blind, Randomized Placebo-Controlled Clinical Investigation With Alteco® LPS AdsorberTerminatedNCT02335723Not applicable
• The Effect of Terlipressin on Intesitnal Function in Septic Shock PatientsStatus unknownNCT02306239Not applicable
• Optimization of Fluid Therapy in Sepsis by a Passive Leg Raising TestTerminatedNCT02301585Not applicable
• Comparison of Sensitivity Between Presepsine and Lactate for the Diagnosis of Severe Sepsis.WithdrawnNCT02300415
• Adsorbtion of Cytokines Early in Septic Shock: the ACESS StudyCompletedNCT02288975
• Evaluation of Impaired Microcirculation During Septic Shock With Contrast Enhanced UltrasoundWithdrawnNCT02277977Not applicable
• Dexmedetomidine on Microcirculation in Septic ShockCompletedNCT02270281Phase 4
• Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic ShockCompletedNCT02266589Phase 3
• Studying Complement Inhibition in Early, Newly Developing Septic Organ DysfunctionCompletedNCT02246595Phase 2
• Meropenem and Ciprofloxacin Dosing in Septic ShockStatus unknownNCT02240277
• Cerebral Oxygenation in Septic Patients Using Vasopressors - the Conscious StudyTerminatedNCT02237833
• Efficacy of IntraVenous ImmunoGlobulins in Toxic Shock Syndromes: a Paediatric Pilot StudyCompletedNCT02219165Phase 2
• Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem During the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care UnitsCompletedNCT02213796Phase 4
• Co-administration of Iloprost and Eptifibatide in Septic Shock PatientsCompletedNCT02204852Phase 2
• Inferior Vena Cava Collapsibility Index in Severe SepsisStatus unknownNCT02195830Not applicable
• Echocardiographic and Arterial Pressure Waveform Changes After Reducing Heart Rate With Esmolol in Septic Shock PatientsCompletedNCT02188888
• Immune Failure in Critical Therapy (INFECT) StudyCompletedNCT02186522
• ARDS Prediction Score in Critically Ill Patients in ChinaCompletedNCT02174081
• Resuscitation Strategies in Septic ShockStatus unknownNCT02150512Not applicable
• Echocardiography in Septic ShockStatus unknownNCT02135796
• Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in SepsisCompletedNCT02135770Phase 3
• Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic ShockActive, not recruitingNCT02120404Phase 2
• Does the Time Between the End of Vascular Filling and Evaluation of Its Effectiveness Modify Fluid Challenge Results in Septic Shock?CompletedNCT02116413
• Effects of Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic ShockCompletedNCT02114710Phase 3
• Effect of Different Strategies for Titrating a High MAP on MicrocirculationCompletedNCT02085291Phase 4
• Conservative vs. Liberal Approach to Fluid Therapy of Septic Shock in Intensive CareCompletedNCT02079402Phase 4
• Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response in Septic ShockWithdrawnNCT02069288Phase 3
• Esmolol Effects on Heart and Inflammation in Septic ShockStatus unknownNCT02068287Phase 2
• Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic ShockStatus unknownNCT02062970Not applicable
• Effect of EGDT on Hepatic Perfusion in Patients With Septic ShockStatus unknownNCT02060773
• Hemodynamic Effects of Vasopressin in Early Septic Shock StageCompletedNCT02053675Not applicable
• The Effect of Midazolam on Fluid Responsiveness in Septic PatientsCompletedNCT02050893Phase 1/2
• Clock Genes in Patients With Refractory Septic Shock (SeptiClock) - Pilot StudyCompletedNCT02044575
• Septic cArdiac Deficiency and MenIngococcal seveRe SepsisCompletedNCT02041663Not applicable
• Statistical Analysis Plan for an Individual Patient Data Meta-analysis of Three, International Trials Comparing Protocolised With Usual Resuscitation in Patients Presenting to the Emergency Department With Severe Sepsis and Septic ShockCompletedNCT02030158
• Efficacy of Mw Vaccine in Treatment of Severe SepsisCompletedNCT02025660Phase 2/3
• A Randomized Controlled Study of Enteral Nutrition in Septic ShockCompletedNCT02025127Not applicable
• Prevalence and Outcome of Hypermetabolism in Initial Prevalence and Outcome of Hypermetabolism in Initial Phase of Intensive Care Unit Patient: a Prospective Observational StudyStatus unknownNCT02002676
• Prehospital Antibiotics Against Sepsis TrialCompletedNCT01988428Not applicable
• Pilot Study for the SQUEEZE TrialCompletedNCT01973907Phase 3
• Early Haemodynamic Optimization Using Preload Dependence During Septic Shock = EHOSS-1CompletedNCT01972828Not applicable
• Investigate the Activity of Endotoxin in Severe SepsisTerminatedNCT01957254
• The Effects of a Polyethyleneimine-coated Membrane (oXiris™) for Hemofiltration Versus Polymyxin B- Immobilized Fibre Column (Toraymyxin™) for Hemoperfusion on Endotoxin Activity and Inflammatory Conditions in Septic Shock- A Randomized Controlled Pilot Study (ENDoX-study)CompletedNCT01948778Not applicable
• Early Use of Norepinephrine in Septic Shock ResuscitationCompletedNCT01945983Not applicable
• International Multicentre Prevalence Study on SepsisCompletedNCT01943747
• Cerebrovascular Autoregulation in Sepsis, Influence of Renal Replacement TherapyWithdrawnNCT01926301
• Focused Ultrasound in Septic Shock PatientsStatus unknownNCT01920776Not applicable
• Venoarterial PCO2 Difference /Arteriovenous O2 Content Difference Ratio as Goal of Early Septic Shock TherapyStatus unknownNCT01877798Not applicable
• Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic ShockCompletedNCT01867905
• Renal Resistive Index and Cardiac Output Changes During Resuscitation Predict the Occurrence of Acute Kidney Injury in Septic Shock PatientsStatus unknownNCT01862588
• Efficacy of Melatonin in Patients With Severe Sepsis or Septic ShockStatus unknownNCT01858909Phase 3
• Upregulation of Alpha-1 Receptors Upon Septic Shock?TerminatedNCT01856517Phase 2/3
• Russian Clinical Trial of Mesenchymal Cells in Patients With Septic Shock and Severe NeutropeniaStatus unknownNCT01849237Phase 1/2
• Effects of Early Exercise Rehabilitation on Long-term Functional Recovery in Patients With Severe SepsisCompletedNCT01845766Not applicable
• Prognostic Evaluation Of Severe Sepsis And Septic Shock. Procalcitonin Versus Delta SofaStatus unknownNCT01841190
• Citrate Versus Heparin Anticoagulation: Effect on Molecules ClearancesStatus unknownNCT01839578Not applicable
• Septic Shock and Delirium Because of rSO2 Abnormalities in Intensive Care Unit Patients (The SAD BRAIN Study)CompletedNCT01836302
• Efficacy and Safety of Monotherapy With Noradrenaline and Terlipressin in Patients of Cirrhosis With Septic Shock Admitted to Intensive Care UnitCompletedNCT01836224Not applicable
• Assessment of Fluid Responsiveness by Elevation of PEEP in Patients With Septic ShockCompletedNCT01827007Not applicable
• Effect of Hydrocortison on Post-ischemic Flow-mediated Dilation and on Thenar Oxygen Saturation in Human Septic Shock.TerminatedNCT01817153Phase 2/3
• Activated Protein C and MicrocirculationCompletedNCT01806428
• Methylene Blue in Severe Sepsis and Septic ShockStatus unknownNCT01797978Phase 3
• Impact of CVVHD With Adsorption Capacity Membranes in Septic Acute Kidney InjuryCompletedNCT01790620Not applicable
• ASpirin for Patients With SEPsis and SeptIc ShockTerminatedNCT01784159Phase 2
• Polydatin Injectable (HW6) for Shock TreatmentStatus unknownNCT01780129Phase 2
• A Retrospective Review of a Comprehensive Cohort of Septic Shock: Assessment of Critical Determinants of OutcomeStatus unknownNCT01775956
• Cytokine Response in Septic ShockStatus unknownNCT01770457
• Cardiac Stress in Septic Shock - Biomarkers, Echocardiography and OutcomeStatus unknownNCT01747187
• Electronic Application of a Severe Sepsis Screening Tool and Management BundleStatus unknownNCT01724463
• Hyperoxia and Hypertonic Saline in Septic ShockTerminatedNCT01722422Not applicable
• Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer PatientsCompletedNCT01718613Phase 3
• Continuos Terlipressin Infusion in Septic ShockStatus unknownNCT01697410Not applicable
• Comparison of ECMO Use and Conventional Treatment in Adults With Septic ShockStatus unknownNCT01685112
• I.D.E.A.L.-I.C.U. (Initiation of Dialysis EArly Versus deLayed in Intensive Care Unit)TerminatedNCT01682590Phase 3
• Bio-clinical Evolutive Dynamic in Patients Suffering From Communitary Septic Shock (Biosepsis)CompletedNCT01668329
• The Effects of Interferon-gamma on Sepsis-induced ImmunoparalysisCompletedNCT01649921Phase 3
• Heparin Anticoagulation to Improve Outcomes in Septic Shock: The HALO PilotCompletedNCT01648036Phase 2
• Examination of ADMA Serum Level and DDAH IICompletedNCT01632059
• Red Blood Cell Transfusion Improves Perfusion Parameters in Septic Shock Patients With HypoperfusionCompletedNCT01611753Not applicable
• Membrane Shedding During Septic ShockCompletedNCT01604551
• Endotoxin in Gram-negative Septic ShockStatus unknownNCT01602354
• Selenium Replacement and Serum Selenium Level in Severe Sepsis and Septic Shock PatientsWithdrawnNCT01601938Phase 2
• Mitochondrial Function of Immune Cells in SepsisCompletedNCT01600989
• Evaluation of Intestinal Brush Border Enzyme Function in Critically Ill PatientsCompletedNCT01585909Not applicable
• Pharmacology of Exenatide in Pediatric SepsisWithdrawnNCT01573806Phase 1/2
• Investigation of the Role of Brain Natriuretic Peptide and Lactate in Early Goal-directed Therapy for Patients With Severe Sepsis and Septic ShockStatus unknownNCT01539551
• Use of PiCCO System in Critically Ill Patients With Septic Shock and Acute Respiratory Distress SyndromeCompletedNCT01526382Phase 1/2
• Procalcitonin Monitoring Sepsis StudyCompletedNCT01523717
• Pharmacokinetic of Doripenem and Piperacillin/Tazobactam in More Than 120 kg Critically Ill PatientsCompletedNCT01517815Not applicable
• Discontinuation Order of Vasopressors in Septic ShockTerminatedNCT01493102Not applicable
• Transfusion-requirements in Septic Shock TrialCompletedNCT01485315Phase 3
• Personalized Mean Arterial Pressure Management on Renal Function During Septic ShockTerminatedNCT01473498Not applicable
• The Cooling And Surviving Septic Shock Study (CASS)TerminatedNCT01455116Phase 2/3
• Emergency Department Management of Sepsis Patients: A Goal-Oriented Non-Invasive Sepsis TrialCompletedNCT01453270Not applicable

← Shock, Septic overview